Abstract-The effect of malotilate (diisopropyl 1,3-dithiol-2-ylidenemalonate) on drug metabolizing activity in rat liver microsomes was examined. Malotilte (500 mg/kg/day) was administered orally to rats for 3 days. The contents of cyto chrome P-450 (P-450) and cytochrome b5 (b5), the activity of NADPH-cytochrome c reductase, and the metabolization of aniline, aminopyrine, benzo(a)pyrene (B(a)P) and 7-ethoxycoumarin (7-EC) in the microsomal fraction were examined 24 hr after the final administration of malotilate. The content of b5 and the activity of NADPH-cytochrome c reductase were increased by the malotilate treatment, but the content of P-450 was not significantly affected. 7-EC 0-deethylation was markedly and aminopyrine N-demethylation was moderately enhanced; in contrast, aniline hydroxylation was significantly and B(a)P hydroxylation was slightly reduced. Such different effects of malotilate among the four substrate-me tabolizing activities may be due mainly to the increase in the content of b5, which participates in the transport of the second electron required for P-450 function to various extents. It is also possible that malotilate affects the population of P-450 subtypes, each having a different substrate specificity and a different affinity for b5.
Diisopropyl
1,3-dithiol-2-ylidenemalonate (malotilate), which has been developed as a drug for liver cirrhosis, has protective effects in rats against liver injuries induced by carbontetrachloride (CC14) (1, 2), ethionine (3), D-galactosamine (4) and many other hepatotoxins (5). It also attenuates the decreases in serum total protein and albumin contents, cholinesterase activity and total cholesterol level in human liver cirrhosis and chronic hepatitis (6).
Malotilate is known to enhance protein synthesis in the liver by accelerating RNA synthesis and/or increasing the transport of RNA from nuclei to cytosol (7). Indeed, it increased the regeneration rate of partial hepatectomized liver in cirrhotic rats (8) and in normal and aloxan-diabetic rats (9) . Malotilate has been reported to affect the hepatic microsomal mixed-function oxidase system. Nakayama (10) first described that malotilate increased the contents of cyto chrome P-450 (P-450) and cytochrome b5 (b5) and aminopyrine demethylase activity in rat liver microsomes and caused changes in the structures of rough and smooth endo plasmic reticulums in hepatocytes. Katoh et al. (11) demonstrated that malotilate charac teristically increased the content of b5 and the activity of NADPH-cytochrome c reductase rather than the content of P-450 in rat liver microsomes. They also reported that p-nitroanisole 0-demethylase activity and N-demethylase activities toward amino pyrine, benzphetamine and ethylmorphine were enhanced, but aniline hydroxylase activity was reduced by malotilate adminis tration (12) . Recently, Kawata et al. (13) showed similar results. However, there are no reports concerning the effect of malo tilate on any other substrate-metabolizing activity.
In the present study, we administered malotilate to rats for 3 days and examined the H. Okuno et al.
activity to metabolize the four substrates, aniline, aminopyrine, benzo(a)pyrene (B(a)P) and 7-ethoxycoumarin (7-EC), which are commonly used substrates for P-450 (14 17) , in the microsomal fraction of the liver.
Materials and Methods Animals and treatments:
Male Sprague Dawley rats each weighing 200 g were given a standard pelleted diet and drinking water ad libitum. Malotilate dissolved in olive oil (10%, w/v) was administered orally to the rats at a dose of 500 mg/kg (1 ml/200 g body weight), once a day for 3 days. Control rats received equivalent volumes of olive oil. The animals were sacrificed 24 hr after the final adminis tration of the drugs. They were fasted for 18 hr prior to killing, but had free access to tap water.
Preparation for 60 min in a preparative ultra centrifuge (Hitachi, 70P-72). The pellet of microsomes was suspended in the homoge nating solution in the homogenizer and centrifuged again as described above. The resulting pellet was suspended in 20 mM potassium phosphate buffer (pH 7.4) con taining 15% glycerol. These operations were done at 0-4'C.
Assays of the contents of P-450 and b5 and the activity of NADPH-cytochrome c reductase: The content of P-450 was assayed by the method of Omura and Sato (18) . The content of b5 and the activity of NADPH cytocrome c reductase were assayed by the method of Omura and Takesue (19) . The microsomal protein content was measured by the method of Lowry et al. (20) .
Assays of substrate-metabolizing activities: Substrate-metabolizing activities, aniline hy droxylation, aminopyrine N-demethylation, B(a)P hydroxylation and 7-EC 0-deethyl ation were assayed as described by Imai et al. (14) , Nash (15), Nebert and Gelboin (16) and Ullrich and Weber (17) , respectively. Each substrate-metabolizing activity was measured using NADPH as the sole electron source.
Results
Liver weight and the microsomal protein content in the liver of malotilate-treated rats: Figure 1 shows the liver weight (/100 g body weight) and the microsomal protein content (/g liver) in the liver of the control and the malotilate-treated rats. The liver weight and the microsomal protein content in the liver of the malotilate-treated group were significantly increased to 156% and 113% of the control level, respectively.
Contents of P-450 and b5 and the activity of NADPH-cytochrome c reductase in malotilate-treated rats: As shown in Fig. 2 , the content of b5 and the activity of NADPH cytochrome c reductase (/mg microsomal protein) of the malotilate-treated group were noticeably increased to 171% and 169% of the control level, respectively. On the other hand, the content of P-450 of the malotilate treated group was decreased to 94.7% of the control level, no significant difference being observed between the malotilate-treated group and the control group. Table 1 shows the contents of P-450 and b5 and the activity of NADPH-cytochrome c reductase per g liver and per mg microsomal protein. They were similarly affected by the malotilate treatment, but the values per g liver were higher than those per mg microsomal protein, which reflects the increase in the microsomal protein content per g liver.
Substrate-metabolizing activities in malo tilate-treated rats: As shown in Fig. 3 , 7-EC 0-deethylase activity (/nmol P-450) in the malotilate-treated group was markedly en hanced to 614% of the control level. Likewise, aminopyrine N-demethylase activity in the malotilate-treated group was moderately increased to 121% of the control level. In contrast, aniline hydroxylase activity was significantly reduced to 72.8% of the control level by the malotilate treatment; B(a)P hydroxylase activity was also decreased to 85.1% of the control level, but no significant difference was observed between the malo tilate-treated group and the control group. 
Discussion
This study confirmed that the content of b5
and the activity of NADPH-cytochrome c reductase were noticeably increased, whereas the content of P-450 was not significantly affected by the malotilate treatment; amino pyrine N-demethylase activity was moderately increased, but aniline hydroxylase activity was significantly reduced, as described by others Fig. 3 . The effect of malotilate on the activities of aniline hydroxylase, aminopyrine N-demethylase, benzo(a)pyrene (B(a)P) hydroxylase and 7-ethoxycoumarin (7-EC) 0-deethylase per nmol cytochrome P-450. (10) (11) (12) (13) .
In addition, 7-EC 0-deethylase activity was preferentially and markedly enhanced to more than 6 times the control level, whereas B (a) P hydroxylase activity was slightly decreased by the malotilate treatment.
Liver microsomes contain two electron transport chains, NADPH-supported and NADH-supported systems. Hildebrandt and Estabrook (21) first suggested the par ticipation of b5, the component of the NADH supported system, in the microsomal mixed function oxidase system, indicating that it provides the second of the two electrons required for P-450 function. Since then, various studies (22-31) have been reported, and it is generally accepted that some cross linking sites exist between the two chains and both of them contribute to the mixed function oxidase system in liver microsomes.
When NADPH is used as the sole electron source as in our experiments, the second electron is provided from NADPH-cyto chrome c reductase either directly or via b5 to P-450. However, the participation of b5 in the transport of the second electron differs among the substrates examined (22-26) as well as the subtypes of P-450 included in the system (25-28) and depends on the con ditions employed, such as the concentration of b5, if the same substrate and P-450 are used (29-31).
NADPH-cytochrome c reductase is the rate-limiting component in the mixed function oxidase system. The fortification of microsomes with purified NADPH-cyto chrome c reductase enhances the drug metabolizing activity, which depends on both the subtype(s) of P-450 and the substrate examined (32, 33). Indeed, some drug metabolizing activities are reduced with the increase in the amount of b5 in reconstituted systems, but partially reversed by the increase in the concentration of NADPH-cytochrome c reductase (31).
The effect of malotilate on various sub strate-metabolizing activities may result from the increases in both the content of b5 and the activity of NADPH-cytochrome c reductase. Studies using the antibody for b5 (23) and reconstituted systems (13, 24) have shown that b5 is not involved in aniline hydroxylation. Therefore, in the case of aniline hydroxylation, P-450 and b5 may compete for the second electron from NADPH-cytochrome c reductase, and the increase in the content of b5 by the malotilate treatment, thus, may inhibit aniline hydroxy lase activity, though the increase in the activity of NADPH-cytochrome c reductase may have partially reversed this inhibition.
7-EC 0-deethylation is markedly enhanced by the addition of b5 in the reconstituted system containing some form of P-450 (P 4501, etc.) (28). The fortification of micro somes with purified NADPH-cytochrome c reductase also increases 7-EC 0-deethylation (32, 33). Therefore, the increases in both the content of b5 and the activity of NADPH cytochrome c reductase by the malotilate treatment may have synergistically enhanced 7-EC 0-deethylase activity. Imai (22) reported that aminopyrine N demethylation was enhanced by the addition of b5 in the reconstituted system containing P-4501. Recently, Kawata et al. (13) that B (a) P hydroxy lation in the reconstituted system containing P-448 was gradually reduced in proportion to the increase in the amount of b5, but partially reversed by the increase in the concentration of NADPH-cytochrome c reductase.
The incorporation of purified NADPH-cytochrome c reductase into micro somal preparations also enhanced B(a)P hydroxylation (32).
In the cases of aminopyrine N-demethyl ation and B(a)P hydroxylation, the extent of the participation of b5 in the transport of the second electron may be between that of aniline hydroxylation and 7-EC 0-deethyl ation. Under the conditions of our experi ments, the increase in the content of b5 by the malotilate treatment may have slightly increased or decreased aminopyrine N demethylase activity and decreased B(a)P hydroxylase activity, although they may have been reversed by the increase in the activity of NADPH-cytochrome c reductase. Kawata et al. (13) recently demonstrated using reconstituted systems that the stimu latory effect of b5 on p-nitroanisole 0 demethylase activity and N-demethylase activities toward aminopyrine and benzphe tamine in the P-450 preparation from malo tilate-treated rats was more conspicuous than that in the preparation from control rats. They suggested that the microsomes of the malotilate-treated rats contained a form(s) of P-450 which required b5 for the maximal activities of the demethylation reactions. In our studies, too, it is possible that ma.lotilate induced a form(s) of P-450 which had a substrate specificity preferential to 7-EC or that which had a high affinity for b5 and accepted the second electron preferentially from b5 in 7-EC 0-deethylation. 275 (1951) 
